MRC - A Benefit-risk Trial Of One-month Rifapentine And Isoniazid To Prevent Tuberculosis

Project: Research project (funded)Research

Project Details

StatusActive
Effective start/end date1/09/2331/08/28

Funding

  • MEDICAL RESEARCH COUNCIL (MRC): £126,858.48